Effective models could unlock some of what is still unknown in biology and help your doctor find the right treatment.

At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

Most people with eczema benefit from the intermittent use of: phototherapy topical or oral steroids nonsteroidal medications, such as methotrexate, azathioprine, or mycophenolate mofetil Biologic ...

Alumis Inc.'s twice-a-day oral drug totally cleared the skin of telltale red, itchy patches in nearly 39% of 80 ...

How many of us know what goes into the development of the medications we take? We take a medicine and hope it will work, that ...

Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...

Biologic disease-modifying antirheumatic drugs (bDMARDs) do not appear to negatively impact fertility among women with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), according to study ...

Micreos Pharmaceuticals AG (”Micreos”), a preclinical-stage biopharmaceutical company, specializing in developing Engineered ...

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...

a real-time analytics tool designed to streamline biosimilar adoption and reduce unnecessary spending on biologic drugs. The Biosimilar Dashboard empowers health plans, employers, pharmacy benefit ...